Stock Events

Stock Events

Vivos 

$0.09
12
+$0+0.83% Today

Statistics

Day High
0.09
Day Low
0.08
52W High
0.17
52W Low
0.04
Volume
60,001
Avg. Volume
522,244
Mkt Cap
38.65M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

19OctExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-10,392.86%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
56,000Revenue
-5.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RDGL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical offers robotic-assisted surgical systems, competing in the broader field of advanced medical technologies, including cancer treatment.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation provides various medical devices used in interventional medical specialties, competing in the oncology space with solutions that may overlap with Vivos' offerings.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc offers medical technologies, services, and solutions, including those for treating cancer, making it a competitor in the medical device and therapy market.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments, competing with Vivos' therapeutic solutions.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its involvement in surgical solutions places it in indirect competition with companies like Vivos in the broader medical device market.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie Inc. engages in the discovery, development, manufacture, and sale of a broad line of pharmaceuticals, including cancer treatments, competing in the pharmaceutical and biotechnology industry against Vivos' therapies.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson operates in the healthcare field, offering products and services, including cancer treatment solutions, which places it in competition with Vivos in the healthcare and medical device sector.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc. is a research-based biopharmaceutical company that develops and manufactures healthcare products including cancer drugs, competing in the pharmaceuticals sector with Vivos.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a global healthcare company that offers cancer treatment solutions, including pharmaceuticals and vaccines, competing in the healthcare and pharmaceutical industry with Vivos.

About

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Show more...
CEO
Dr. Michael K. Korenko Ph.D.
Employees
1
Country
US
ISIN
US92858K2042

Listings

OTC Link
US
RDGL

0 Comments

Share your thoughts

FAQ

What is Vivos stock price today?▼
The current price of RDGL is $0.09 USD — it has increased by +0.83% in the past 24 hours. Watch Vivos stock price performance more closely on the chart.
What is Vivos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vivos stocks are traded under the ticker RDGL.
Is Vivos stock price growing?▼
RDGL stock has fallen by -5.45% compared to the previous week, the month change is a +7.73% rise, over the last year Vivos has showed a -26.91% decrease.
What is Vivos market cap?▼
Today Vivos has the market capitalization of 38.65M
What were Vivos earnings last quarter?▼
RDGL earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vivos revenue for the last year?▼
Vivos revenue for the last year amounts to 56,000 USD.
What is Vivos net income for the last year?▼
RDGL net income for the last year is -5.82M USD.
How many employees does Vivos have?▼
As of April 06, 2026, the company has 1 employees.
In which sector is Vivos located?▼
Vivos operates in the Health Care sector.
When did Vivos complete a stock split?▼
The last stock split for Vivos was on June 28, 2019 with a ratio of 1:8.
Where is Vivos headquartered?▼
Vivos is headquartered in Kennewick, US.